| Literature DB >> 17888816 |
Isabella Pacchiarotti1, Lorenzo Mazzarini, Patrizia Pellegrini, Viola Venturelli, Gabriele Sani, José Sánchez-Moreno, Iginia Mancinelli, Roberto Tatarelli, Giorgio D Kotzalidis, Paolo Girardi.
Abstract
A 41-year-old woman with breast cancer developed a manic episode while being treated with a 5-fluorouracil-epirubicin-cyclophosphamide combination (most likely caused by the first drug). Chemotherapy was discontinued, and antipsychotic treatment with haloperidol and olanzapine was instituted. She recovered after 10 days. Normal computerized tomography (CT) scans and neurological examinations were consistent with the absence of neurological symptoms on physical exam.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17888816 DOI： 10.1016/j.genhosppsych.2007.04.007
Source DB: PubMed Journal: Gen Hosp Psychiatry ISSN： 0163-8343 Impact factor: 3.238